Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antigen presentation and macrophages]

A Toubert1, D Charron

  • 1INSERM U.396, Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, Paris, France.

Pathologie-Biologie
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: Where do we stand? Volume II.

Frontiers in immunology·2022
Same author

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome.

Nature medicine·2022
Same author

Corrigendum to "Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease" [Hum. Immunol. (2016) 35-40].

Human immunology·2020
Same author

Identification of Novel Human Monocyte Subsets and Evidence for Phenotypic Groups Defined by Interindividual Variations of Expression of Adhesion Molecules.

Scientific reports·2020
Same author

Recovery of central memory and naive peripheral T cells in Follicular Lymphoma patients receiving rituximab-chemotherapy based regimen.

Scientific reports·2019
Same journal

Pathologie-biologie·2020
Same journal

Antibacterial and antibiofilm activities of Laurus nobilis L. essential oil against Staphylococcus aureus strains associated with oral infections.

Pathologie-biologie·2015
Same journal

[Not Available].

Pathologie-biologie·2015
Same journal

Oxidative damage and histopathological changes in lung of rat chronically exposed to nicotine alone or associated to ethanol.

Pathologie-biologie·2015
Same journal

Biological diagnosis of diabetes mellitus.

Pathologie-biologie·2015
Same journal

Association of CagPAI integrity with severeness of Helicobacter pylori infection in patients with gastritis.

Pathologie-biologie·2015
See all related articles

T-cells recognize peptides via Human Leukocyte Antigen (HLA) molecules. Class I HLA presents endogenous antigens to CD8+ T-cells, while Class II HLA presents exogenous antigens to CD4+ T-cells.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Context:

  • T-cell recognition of antigenic peptides is crucial for adaptive immunity.
  • Human Leukocyte Antigen (HLA) molecules, divided into Class I and Class II, present these peptides.
  • The presentation pathways involve distinct cellular machinery and peptide sources.

Purpose:

  • To elucidate the distinct mechanisms of antigen presentation by Class I and Class II HLA molecules.
  • To highlight the molecular players involved in HLA biosynthesis and peptide loading.
  • To introduce the concept of exogenous antigen presentation by Class I molecules.

Summary:

  • Class I HLA molecules present endogenous peptides to cytotoxic CD8+ T-cells, utilizing proteasomes and TAP transporters.
  • Class II HLA molecules present exogenous peptides, acquired via endocytosis, to helper CD4+ T-cells, involving invariant chain and HLA-DM.

Related Experiment Videos

  • Recent findings suggest exogenous antigen presentation by Class I HLA, particularly in phagocytic cells like macrophages.

    • Impact:

    • Provides a foundational understanding of T-cell-mediated adaptive immune responses.
    • Clarifies the molecular basis of antigen processing and presentation.
    • Opens avenues for understanding immune evasion and developing targeted immunotherapies.